Breaking AI & Tech News Analyzed

The Journey from Prototype to ClearanceBuilding a medical device is fundamentally different from standard software development. This week on Build Mode, host Isabelle Johannessen sat down with Robhy Bustami, co-founder and CEO of BioticsAI, to discuss the arduous path from a $100,000 prototype to FDA clearance. Bustami, a Startup Battlefield winner, detailed how his team is building an AI copilot for ultrasound designed to detect fetal abnormalities. The conversation revealed that the traditional startup mantra of 'move fast and break things' is obsolete in the medical sector, replaced by a necessity for extreme precision and coordination.Market Validation and Resource AllocationThe episode provides a strategic look at the 'data' driving medtech success. BioticsAI's recognition as a Startup Battlefield winner serves as a key validation of their technology's potential. However, Bustami emphasized that the primary data point for founders is not just market traction, but the successful navigation of complex regulatory pathways. This requires a significant reallocation of resources—shifting focus from rapid feature deployment to ensuring safety, reliability, and compliance with FDA standards.Shifting the MedTech CultureThe core impact of this discussion lies in the cultural shift it highlights for the industry. As timelines for FDA approval remain uncertain, the ability to maintain team morale and investor confidence becomes a critical operational metric. Bustami noted that building in a regulated industry requires a foundation of trust rather than speed. This signals a broader trend where medtech startups must balance the pressure of hyper-growth with the ethical and legal responsibilities of patient safety.The Future of AI in Healthcare RegulationLooking ahead, the medtech landscape will likely see a consolidation of companies that prioritize long-term compliance over short-term hype. As more AI copilots enter the market, the winners will be those founders who master the art of 'slow and steady' innovation. The next wave of medical breakthroughs will depend not just on algorithmic superiority, but on the ability to build sustainable organizations capable of weathering the regulatory storm.

The Challenges of FDA Approval Surviving the long road to FDA approval isn’t just about building great technology — it’s about keeping your team motivated, finding the right investors, and learning how to operate when timelines are uncertain. Lessons from BioticsAI This week on Build Mode, Isabelle Johannessen sits down with Robhy Bustami, co-founder and CEO of BioticsAI, a Startup Battlefield-winning company building an AI copilot for ultrasound to help detect fetal abnormalities. From a $100,000 prototype to FDA clearance, Bustami shares what it actually takes to build in one of the most regulated industries in the world. Building a Medtech Startup In this episode, they break down what it really looks like to build a medtech startup, including where you can’t “move fast and break things” and that every milestone takes time, coordination, and trust. Key Takeaways Team motivation is crucial during the long FDA approval process Finding the right investors is essential for medtech startups Adaptability is key when dealing with uncertain timelines Future Outlook As the medtech industry continues to evolve, startups like BioticsAI will play a critical role in shaping the future of healthcare technology. With the right approach and mindset, these companies can overcome the challenges of FDA approval and make a lasting impact.

Blockx’s Historic Run in the Spanish CapitalBelgian rising star Alexander Blockx has delivered a performance of a lifetime at the Madrid Open, defeating defending champion Casper Ruud 6-4, 6-4 to secure a spot in the semi-finals. The 21-year-old, ranked 69th, has defied all odds to reach the last four, marking his best result on clay to date.Scoreline: Blockx defeated Ruud in straight sets (6-4, 6-4).Ranking Milestone: He is the fourth lowest-ranked player to reach the men's semi-finals in Madrid.Performance: He is 4-2 against top 20 opponents this month, with all four wins coming in the last three weeks.“To be honest, I’m just happy with being here,” Blockx said. “Semi-finals is something I wouldn’t have even dreamed of to begin with.” The conditions in Madrid, characterized by slow clay and high altitude, have seemingly suited Blockx’s aggressive style, allowing him time to settle and dictate points.Ruud’s Historic Fall from GraceCasper Ruud’s loss marks a significant downturn in the Norwegian’s career trajectory. The defeat sees Ruud exit the top 20 for the first time since May 2021, signaling a potential shift in the hierarchy of men's clay-court tennis. Ruud, who had been the defending champion, struggled to find rhythm against the relentless pressure of Blockx’s game.The WTA Final and Alcaraz’s AbsenceOn the women's side, 19-year-old Mirra Andreeva battled nerves to defeat Hailey Baptiste 6-4, 7-6 (8), securing her place in the Madrid final. Andreeva, who turned 19 on Wednesday, boasts an impressive 12-1 record on clay this season. Her victory comes after a dramatic second set tie-break where she saved three set points to overcome the American.Simultaneously, the tournament was dealt a blow with the withdrawal of world No. 2 Carlos Alcaraz. The Spanish superstar is sidelined due to a right wrist injury, a setback that will prevent him from defending his French Open title in three weeks. Alcaraz was present in the stands, however, cheering on his younger brother Jaime in an under-16 tournament.Future Outlook: A New Era DawningThe Madrid Open is rapidly becoming a proving ground for the next generation of tennis talent. With Blockx and Andreeva reaching deep stages, the sport is witnessing a generational transition. For Blockx, a semi-final appearance at a Masters 1000 event is a statement of intent, suggesting he could be a major force to be reckoned with on clay in the coming years. For Ruud, the focus will shift to recovery and recalibrating his game to reclaim his position among the elite.

The Trial Continues Elon Musk's court case against Sam Altman continues on Thursday, after a day of contentious exchanges during OpenAI's cross-examination of the Tesla CEO. Musk will face another round of questioning before his lawyer calls more witnesses, including OpenAI's president, Greg Brockman. The Dispute Over OpenAI's Founding Witness testimony and evidence has revealed formerly private emails, text messages and diary entries surrounding the formation of OpenAI, giving a behind-the-scenes look at how the tech behemoth was created. Many of the tech industry's most powerful players are named as witnesses and will give their account on the origins of Musk and Altman's bitter feud. Altman is set to testify later in the trial, which will last three weeks. Musk's Allegations Against OpenAI Musk, who co-founded OpenAI in 2015, is arguing that Altman, Brockman and OpenAI broke a foundational agreement when they shifted the company from a non-profit intent on bettering humanity into a for-profit structure. Musk claims that Altman and Brockman unjustly enriched themselves and should be removed from the company. He is also seeking the undoing of the for-profit conversion and $134bn in damages to be redirected to OpenAI's non-profit arm. OpenAI's Response OpenAI rejects Musk's allegations and is attempting to show that he was always aware of plans for creating a for-profit entity. The AI firm's attorneys have stated Musk is "motivated by jealousy" of OpenAI's success after he left the company in 2018 after a failed attempt to take control. OpenAI has emphasized that it is still overseen by a non-profit. The Implications of the Trial The trial, which began on Monday with jury selection at a federal courthouse in Oakland, California, has already produced dramatic moments and bold accusations. Musk and OpenAI's lead attorney William Savitt spent most of Wednesday in a heated back and forth, with the world's richest person becoming noticeably frustrated and saying that Savitt's questions "are designed to trick me". The Future of OpenAI Silicon Valley is intently watching the trial for both its blockbuster testimony and the potential effects it will have on the AI industry. OpenAI is intending to go public later this year at around a $1tn valuation, but if Musk succeeds in this case, it could greatly complicate that effort – an outcome that would also benefit Musk's own xAI artificial intelligence firm.

Salesforce's AI Roadmap Strategy Artificial intelligence continues to advance at a dizzying clip, forcing enterprises to develop and release new products quicker than ever or risk becoming irrelevant to a faster-moving competitor. Salesforce believes it has found a strategy that allows it to keep up even if it isn’t clear where AI is headed next. The customer management software giant is crowdsourcing its AI roadmap in real time. Crowdsourcing AI Development Salesforce is certainly not the only company to work intimately with its customers for feedback on its products. However, it’s notable considering the sheer size of the company, the pace of new product launches or fixes to existing ones, and the granular level of these relationships. These aren’t annual or even quarterly discussions. Salesforce is meeting with some customers as often as once a week. The Benefits of Customer Feedback “The 18,000 customers are a wellspring of information and a wealth of information that is really needed to get to customer success,” Jayesh Govindarajan, executive vice president at Salesforce AI, told TechCrunch in a recent interview. “The stack that we’ve built has resonated with these customers. Over time we can get context to be better, and as it gets better, and LLMs get better, agent systems do more and more fully autonomous behaviors. That’s a long-running innovation track and we’re going to invest in that.” Rapid Product Releases Salesforce credits its customers for the rate of its product releases. The company told TechCrunch that by letting its customers lead the way, it is able to build an AI product roadmap that can quickly react to where AI technology is headed. Customer Success Stories Engine, a travel management platform, meets with Salesforce weekly and gets access to AI tools before they’re released. PenFed, a federal credit union, developed an IT service management (ITSM) workflow on its own using existing tools and agents in Agentforce that worked well for the company. The Future of AI Development This strategy also allows the company to roll out solutions and workflows built by users to its broader customer base too. However, the downside to this approach is that it relies on the classic service sentiment that the customer is always right. Salesforce is hoping they are despite many enterprises still figuring out what role AI will play in their business, and many having yet to find value from the tech.

Manchester United's Transfer Strategy Manchester United is actively pursuing West Ham's left-back El Hadji Malick Diouf to provide competition for Luke Shaw. Diouf, a 21-year-old Senegal international, joined West Ham for €22m (£19m) from Slavia Prague and has become a crucial player for the team. Diouf's Potential and Stats Diouf's defensive skills have improved, and his crossing ability has added to his attacking threat. West Ham is aware of United's interest but may listen to offers depending on their relegation battle status. The Mainoo Contract Extension In a separate move, Kobbie Mainoo has signed a new contract with Manchester United until June 2031, earning a basic salary of about £120,000 a week. Mainoo, 21, has impressed since his first league start and is seen as a potential star by the club's director of football, Jason Wilcox. United's Midfield Priorities Manchester United is initially focusing on strengthening their midfield, with targets including Atalanta's Éderson, Newcastle's Sandro Tonali, and Nottingham Forest's Elliot Anderson. The club may also consider a left-winger or a defensive player to compete with Shaw. Financial Context West Ham's financial position, marked by losses of £104.2m for the year ending 31 May 2025, might influence their willingness to sell players this summer.

The Palantir Manifesto ControversyJust weeks after publishing a manifesto on X that implied some cultures are inferior to others, described by one UK MP as the "ramblings of a supervillain," the US spy tech company Palantir faces growing calls for a ban in Australia. The company, which has significant government contracts in Australia, now claims it is "just a software company" amid mounting public and political backlash.Cultural Statements Spark Global ConcernEarlier this month, Palantir published a manifesto on X, arguing the benefits of American power and stating: "Some cultures have produced vital advances; others remain dysfunctional and regressive." This public pronouncement, combined with concern over Palantir's software being used by ICE immigration enforcement in the United States and the Israeli military, has led to calls in Australia and the UK for governments to cease using Palantir in their operations.Financial Footprint in Australian GovernmentState and federal contracts with Palantir in Australia have reached nearly $80m, with federal investment in the company reportedly more than $160m. Federal agencies including the financial intelligence agency Austrac and the defense department have spent an estimated $60m in contracts with Palantir. Australia's sovereign wealth fund, the Future Fund, holds $100m worth of shares in the company. In Victoria, the prison system has spent nearly $20m on Palantir contracts since 2012, with a current contract valued at $9m and not due to expire until 2028.Government Response and Company DefenseAustralian Greens senator David Shoebridge has called for a "blanket ban on all new contracts with Palantir, pending a comprehensive public audit of their existing Government agreements." In response, a Palantir spokesperson emphasized that the company is "proud its software supports the Australian defense force and other government agencies" and claimed, "We don't collect or monetize data – we simply provide the tools to help customers organize and understand their own information."Regulatory Scrutiny and Future ImplicationsPalantir has identified Australia as a lucrative market for its surveillance software, achieving "protected level" in the Australian Signals Directorate's information security program. However, questions remain about compliance with the Commonwealth supplier code of conduct, which requires suppliers to avoid bringing the federal government into disrepute. With the recent termination of its lobbying relationship with Cmax Advisory and growing public concern, Palantir's future in Australia's government sector faces significant uncertainty as political pressure mounts for greater transparency and accountability.

Lindsey Vonn is still grappling with the physical and emotional fallout from her crash in the women’s downhill at the 2026 Winter Olympics in Cortina d’Ampezzo. While she has made strides in rehab, the decision to race again remains on hold as she faces additional surgery and a lengthy recovery timeline. Olympic Crash Leaves Vonn Facing a Prolonged Recovery On February 8, 2026, Vonn crashed just 13 seconds into the downhill run, sustaining a complex left tibia fracture that nearly required amputation. The injury forced her out of a season where she led the World Cup downhill standings and had never finished worse than fourth. Recovery Numbers: Surgeries, Timeline, and Physical Setbacks Eight surgeries already performed since the crash, covering fracture fixation and soft‑tissue repair. One additional surgery needed to remove metal hardware and reconstruct the ACL. Estimated 6‑9 months post‑ACL surgery before she can train at full capacity. Overall, Vonn projects a minimum of 18 months before she could consider competitive skiing again. She has progressed from a wheelchair to crutches and expects to begin short walks within a week, but full mobility remains months away. Implications for U.S. Alpine Skiing and Athlete Health Management Vonn’s situation underscores the high‑risk nature of downhill skiing and raises questions about long‑term athlete health protocols. Her experience may prompt U.S. Ski & Snowboard to revisit injury‑prevention strategies, especially for veteran athletes returning after extended absences. Additionally, Vonn’s partnership with biopharma firm Invivyd highlights a growing trend of elite athletes endorsing medical‑technology campaigns, potentially influencing public perception of advanced treatment options. What Lies Ahead: Possible Return Timeline and Retirement Scenarios Vonn has not spoken to her medical team about a definitive comeback plan, preferring to focus on the current recovery phase. She indicated that any competitive return would not be realistic until the 2027‑2028 season at the earliest. Possible outcomes include: Full comeback: Completing the remaining surgery, rehabilitating the ACL, and returning to training for a 2028 Olympic bid. Retirement: Choosing to end her racing career, which would add to her legacy of 84 World Cup wins, second only to Mikaela Shiffrin. Extended hiatus: Remaining involved in the sport through mentorship or commentary while focusing on health. Vonn’s own words capture her mindset: “Tell me I can’t, and I’ll prove you wrong,” reflecting both her competitive spirit and the uncertainty that lies ahead.

The Lead: A New Maritime Flashpoint EmergesThe Panama Canal has emerged as the latest maritime flashpoint, with the United States and China exchanging barbs in recent weeks over influence in what is one of the world's most important shipping routes. This dispute comes amid broader tensions over the Strait of Hormuz, raising concerns about disruptions to global trade and the potential erosion of international maritime laws.The Event Details: Accusations and Denials Over Canal ControlIn a joint statement with Bolivia, Costa Rica, Guyana, Paraguay, Trinidad and Tobago, the US condemned what it called "China's targeted economic pressure" and actions that have "affected Panama-flagged vessels." The countries accused China of detaining Panama-flagged ships in its own ports, claiming these actions are "a blatant attempt to politicise maritime trade and infringe on the sovereignty of the nations of our hemisphere."China strongly denied the allegations, calling them "hypocritical" and accusing the US of politicizing global commerce and undermining sovereignty. Lin Jian, a spokesperson for China's Ministry of Foreign Affairs, asked rhetorically: "Who occupied the Panama Canal for a long time, invaded Panama with its military, and arbitrarily trampled on its sovereignty and dignity?"The crisis stems from Panama's Supreme Court scrapping in January a longstanding concession held by a Hong Kong-linked company to operate the Balboa and Cristobal ports. This decision came amid sustained US pressure on Panama to curb Chinese influence around the canal.The Data Analysis: Global Trade at RiskAnalysts have warned that any disruption to the canal, even temporarily, could "disrupt global trade significantly." According to Ferdinand Rauch, a professor of economics at the University of St Gallen in Switzerland, "It would lead to temporary supply bottlenecks, stock market volatility, inflationary upward pressure and could dampen global GDP measurably if prolonged."The Panama Canal accounts for about six percent of global trade, while the Strait of Hormuz, through which one-fifth of the world's oil and liquefied natural gas (LNG) supplies are shipped during peacetime, has been effectively closed since the US and Israel started bombing Iran on February 28. Currently, some 2,000 vessels are stranded at either end of the strait, while others have been rerouted, come under fire or even been seized.The Impact Analysis: Erosion of Maritime NormsThese frictions point to a broader shift in international shipping, demonstrating that major powers are increasingly willing to contest control of global shipping lanes. Abdul Khalique, a professor at Liverpool John Moores University in the UK, said "rising geopolitical rivalry" is increasingly "spilling into maritime chokepoints, from the Panama Canal to the Strait of Hormuz."The situation has raised questions over whether longstanding international laws governing the world's seas are beginning to unravel. James Kraska, Charles H Stockton Chair of International Law at the US Naval War College, noted that while the ongoing maritime crisis between the US and Iran is unlikely to become a permanent feature, strong international opposition to the unilateral closure of major sea lanes will be a key factor driving a resolution.The Prediction: Adapting to a Volatile Maritime FutureWhile experts disagree on whether this represents a "new normal" for global shipping, there are signs that governments and firms are "already adapting pragmatically: diversifying supply chains, revising risk premiums, increasing naval coordination, and investing in alternative routes," according to Khalique.UPF Barcelona School of Management professor Stephan Maurer warned that the consequences of disruption to or even closure of the Panama Canal for global trade "could be very grave, depending on the degree of disruption." Trade would adapt, but alternatives would greatly increase distances to be covered, with South American countries being most impacted, while the US and Canada would also be "severely affected."